M 617 (Levetiracetam 750 mg)
Pill with imprint M 617 is White, Capsule-shape and has been identified as Levetiracetam 750 mg. It is supplied by Mylan Pharmaceuticals Inc..
Levetiracetam is used in the treatment of seizures; epilepsy; neuralgia; bipolar disorder; hyperekplexia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 617
Levetiracetam
- Imprint:
- M 617
- Strength:
- 750 mg
- Color:
- White
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Pyrrolidine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
triacetin
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 51079-0822 | UDL Laboratories Inc. |
More about levetiracetam
- Levetiracetam Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 263 Reviews
- Drug class: pyrrolidine anticonvulsants
Consumer resources
- Levetiracetam
- Levetiracetam Extended-Release Tablets
- Levetiracetam Injection
- Levetiracetam Oral-Disintegrating Tablets/Tablets for Oral Suspension
- Levetiracetam Oral Solution
- ... +3 more
Other brands: Keppra, Keppra XR, Roweepra, Spritam, Roweepra XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
